Welcome to Nirmay Pharma

Founded in 2003 and headquartered at the Brahmaputra Industrial Park in Amingaon, Guwahati, Nirmay Pharma Pvt. Ltd. is a privately-held, family-managed pharmaceutical manufacturer operating two WHO-GMP certified production units at the same campus in Kamrup Metro, Assam.

We specialize in generic formulations across four therapy areas — Cardiovascular, Diabetes Care, Anti-Infective, and Gastrointestinal — manufactured under rigorous quality systems aligned with WHO-GMP, ICH Q7/Q9/Q10 guidance, and ISO 9001:2015. Our products are supplied to institutional buyers across India and export partners in Nepal, Myanmar, Sri Lanka, Kenya and Ethiopia.

Why Choose Nirmay?

• Manufacturing Scale

  Two WHO-GMP certified units on a single campus at Amingaon, with combined licensed capacity of over 700 million units per annum.

• Quality You Can Trace

  In-house QA/QC laboratories with HPLC, dissolution, and stability chambers at every site.

• Regulatory Strength

  Registered exporter in five countries. Inspection-ready documentation across all units.

• Regional Depth

  Over two decades of continuous operation in the North-East, reinvested locally.

Our Therapy Divisions

Division	Primary Dosage Forms	Manufactured At
Cardiovascular	Tablets, film-coated tablets	Unit 1, Amingaon
Diabetes Care	IR tablets, SR tablets, FDCs	Unit 1, Amingaon
Anti-Infective	Tablets, capsules, dry syrups	Unit 1 & Unit 2
Gastrointestinal	Tablets, capsules, suspensions	Unit 2, Amingaon

Complete Product List »

Manufacturing Footprint

• 

  Unit 1 — Plot 12, Amingaon BIP

  Our primary oral solid dosage facility — tablets, film-coated tablets, and hard-gelatin capsules — with a segregated beta-lactam block. Commissioned 2005.

• 

  Unit 2 — Plot 14, Amingaon BIP

  Adjacent liquid orals and semi-solids facility — syrups, dry syrups, suspensions, ointments, and creams. Commissioned 2011.